CVS Health to support Anthem’s newly launched IngenioRx PBM
WOONSOCKET, R.I. — Health benefits company Anthem’s new pharmacy benefits manager IngenioRx will be getting an assist from CVS Health. The companies inked a five-year agreement that will see CVS Health’s Caremark PBM managing such services as claims processing and prescription fulfillment services for IngenioRx.
CVS Health also will leverage its CVS Pharmacy and MinuteClinic assets to bring its point-of-sale patient messaging and engagement tools to bear on its support of IngenioRx. The company said that by broadening the scope of clinical services offered at the pharmacy, it would drive better health outcomes.
“We believe that this agreement further validates the important role that CVS Health's integrated and innovative pharmacy care model plays in today's health care system and we look forward to working with Anthem and IngenioRx to provide services to help ensure coordinated, holistic care for their PBM members,” CVS Health president and CEO Larry Merlo said. “At CVS Health, we truly are the front door of health care, with nearly 5 million Americans walking into a CVS Pharmacy every day. Given our presence in the community, our pharmacists and nurse practitioners are able to engage in face-to-face personalized counseling and clinically-effective interventions that will enable us to help improve health outcomes and lower overall health care costs for Anthem and its members.”
The agreement will go into effect on Jan. 1, 2020.
“This combination, paired with the clinical expertise, deep provider relationships and focus on customer centricity of Anthem’s affiliated health plans, will create a holistic, integrated approach to managing health and driving better outcomes,” Anthem EVP commercial and specialty division Brian Griffin said “In partnership with CVS, transitioning members seamlessly to our new solution will remain Anthem’s top priority.”
Q&A: Anda’s Chip Phillips talks company’s 25-year growth
Teva introduces Testim generic
JERUSALEM — Teva on Wednesday announced the introduction of its generic of Testim (testosterone gel, 1%). The company received approval for the generic from the Food and Drug Administration in September.
Teva’s generic is available as 50 mg in a 5-gm tube. The product is indicated for testosterone replacement therapy in adult males for conditions associated with the deficiency or absence of endogenous testosterone. It carries a boxed warning for secondary exposure to testosterone.